SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-117099
Filing Date
2022-11-10
Accepted
2022-11-10 16:01:19
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230245d1_8k.htm   iXBRL 8-K 27063
2 EXHIBIT 99.1 tm2230245d1_ex99-1.htm EX-99.1 82860
6 GRAPHIC tm2230245d1_ex99-1imag001.jpg GRAPHIC 10047
  Complete submission text file 0001104659-22-117099.txt   313219

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mist-20221110.xsd EX-101.SCH 3054
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20221110_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20221110_pre.xml EX-101.PRE 22609
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2230245d1_8k_htm.xml XML 3875
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 221376885
SIC: 2834 Pharmaceutical Preparations